A detailed history of Trv Gp Iii, LLC transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Trv Gp Iii, LLC holds 339,160 shares of PLRX stock, worth $4.52 Million. This represents 100.0% of its overall portfolio holdings.

Number of Shares
339,160
Previous 339,160 -0.0%
Holding current value
$4.52 Million
Previous $5.88 Million 4.44%
% of portfolio
100.0%
Previous 100.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

SELL
$18.12 - $30.56 $27.2 Million - $45.8 Million
-1,500,000 Reduced 81.56%
339,160 $6.15 Million
Q4 2022

Feb 14, 2023

SELL
$17.0 - $25.43 $34 Million - $50.9 Million
-2,000,000 Reduced 52.09%
1,839,160 $35.6 Million
Q3 2022

Nov 03, 2022

SELL
$7.67 - $24.23 $15.3 Million - $48.5 Million
-2,000,000 Reduced 34.25%
3,839,160 $80.2 Million
Q2 2020

Aug 07, 2020

BUY
$21.3 - $35.26 $124 Million - $206 Million
5,839,160 New
5,839,160 $190 Million

Others Institutions Holding PLRX

About PLIANT THERAPEUTICS, INC.


  • Ticker PLRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,682,000
  • Market Cap $649M
  • Description
  • Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...
More about PLRX
Track This Portfolio

Track Trv Gp Iii, LLC Portfolio

Follow Trv Gp Iii, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trv Gp Iii, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Trv Gp Iii, LLC with notifications on news.